NCT02403375View on ClinicalTrials.gov

Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 17, 2015

Primary Completion Date

October 26, 2017

Study Completion Date

October 26, 2017

Conditions
Diabetes Mellitus Type 1
Interventions
DEVICE

Accu-Chek Insight Pump System

Continuous subcutaneous insulin infusion pump

Trial Locations (9)

1090

Medical University of Vienna-Dept of Pediatrics, Vienna

6020

Universitatsklinik fur PadiatrieI, Padiatrische Diabetologie und Endokrinologie, Innsbruck

8036

Medical University Graz, Graz

30173

Kinderkrankenhaus auf der Bult, Hanover

32051

Gemeinschaftspraxis für Kinder- und Jugendmedizin, Herford

48155

Practice for Pediatric and Adolescent Diabetology, Münster

72076

Universitatsklinikum Tubingen, Tübingen

B46NH

Birmingham Children's Hospital Foundation Trust, Birmingham

LS97TF

St. James's University Hospital, Leeds

All Listed Sponsors
collaborator

Roche Diabetes Care

INDUSTRY

lead

Hoffmann-La Roche

INDUSTRY

NCT02403375 - Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes | Biotech Hunter | Biotech Hunter